AI In Pharma Market Trends, Industry Insights Report 2025 - 2034


The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.

How Is the AI In Pharma Market Growth Forecast from 2026 to 2030?
The AI in pharma market size has grown exponentially in recent years. It will grow from $3.78 billion in 2025 to $4.79 billion in 2026 at a compound annual growth rate (CAGR) of 26.9%. The growth in the historic period can be attributed to growth of pharmaceutical R&D spending, expansion of biomedical data, need for faster drug development, adoption of computational biology, rise of chronic diseases.

The AI in pharma market size is expected to see exponential growth in the next few years. It will grow to $11.12 billion in 2030 at a compound annual growth rate (CAGR) of 23.4%. The growth in the forecast period can be attributed to precision medicine adoption, AI based clinical trials, demand for cost efficient drug discovery, growth of personalized therapies, integration of genomics data. Major trends in the forecast period include AI driven drug discovery, clinical trial optimization, predictive disease modeling, real time patient data analytics, automated research and development.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/report/ai-in-pharma-global-market-report

What Are the Leading Growth Factors in the AI In Pharma Market?
The rising adoption of cloud-based applications and services by pharmaceutical companies is expected to propel the growth of the AI in pharma market going forward. Cloud-based drug discovery platforms are a cutting-edge method of conducting research and development in the pharmaceutical industry. They leverage data analytics and cloud computing technologies to enhance drug discovery procedures, offering a wide range of tools and functionalities necessary for different facets of drug research and discovery. These platforms improve the efficiency, economy, and collaboration of the processes. Pharmaceutical companies are significant market participants and end-users of these platforms, which help these companies handle large amounts of clinical, chemical, and biological data by providing secure data storage options. For instance, in 2025, according to the Eurostat, a Luxembourg-based statistical office of the European Union, in 2023, 45% of EU businesses purchased cloud computing services. Large enterprises were significantly more inclined to adopt cloud solutions than SMEs, with 78% of large businesses using cloud services compared to 44% of SMEs. Therefore, the increasing adoption of cloud-based applications and services by pharmaceutical companies will drive the AI in pharma market growth during the forecast period.

What Are the Emerging Segments in the AI In Pharma Market?
The AI in pharma market covered in this report is segmented –

1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning
2) By Drug Type: Small Molecule, Large Molecules
3) By Application: Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction

Subsegments:
1) By Context-Aware Processing: Real-Time Data Processing, Contextual Recommendation Systems, Adaptive Learning Systems
2) By Natural Language Processing (NLP): Text Analytics And Sentiment Analysis, Chatbots And Virtual Assistants, Document And Data Mining
3) By Querying Method: Structured Querying, Unstructured Querying, Semantic Search Technologies
4) By Deep Learning: Neural Networks For Drug Discovery, Image Recognition For Medical Imaging, Predictive Analytics Models

Which Trends Are Expected to Redefine the AI In Pharma Market Landscape?
Major companies operating in the AI in pharma market are focusing on developing technological advancements such as AI-powered medical consultation enhancement tools to improve diagnostic accuracy, streamline clinical workflows, and support timely decision-making for healthcare professionals. AI-powered medical consultation enhancement tools use large language models (LLMs) to generate clinical summaries, automate documentation, and interpret patient-provided information to optimize physician efficiency. For instance, in October 2023, Ubie Inc., a Japan-based medical AI startup, introduced a generative AI–driven feature for doctors that streamlines medical record documentation and summarizes patient findings. The feature, known as the medical interview summary function, uses an LLM to automatically condense 20–30 patient responses related to symptoms and lifestyle habits collected through the Ubie Medical Navi platform. By presenting concise summaries directly on the doctor’s screen, the tool allows physicians to quickly understand patient concerns, reduce administrative burden, and improve the overall quality and speed of medical consultations.

Which Are the Key Companies Shaping the AI In Pharma Market Landscape?
Major companies operating in the AI in pharma market are Concerto HealthAI; Alphabet Inc.; OWKIN; Nvidia Corporation; PathAI; Insilico Medicine; Exscientia; Microsoft Corporation; XtalPi; Intel; Standigm; Takeda Pharmaceutical Company Ltd.; Otsuka Pharmaceutical Co. Ltd.; DeepMind; GlaxoSmithKline; Sanofi; Bayer; Renalytix AI; Merck; AstraZeneca; Iktos; Benevolent AI; Novartis; Ardigen; Botkin; Webiomed; Care Mentor AI; Diagnocat; IBM Corporation; Atomwise Inc.; Cloud Pharmaceuticals; Bioage; NuMedii; Envisagenics; Aria Pharmaceuticals; Verge Genomics; Berg LLC; Cyclica; IQVIA; Roche; Pfizer; PRA Health Sciences; Oncora Medical; Recursion Pharmaceuticals Inc.; Nucleai; Pepticom; Rology; hearX Group; iNNOHEALTH Technology Solutions

Get the full ai in pharma market report here:
https://www.thebusinessresearchcompany.com/report/ai-in-pharma-global-market-report

Which Region Is Projected to Account for the Largest Share of the AI In Pharma Market?
North America was the largest region in the AI in pharma market in 2025. The regions covered in the AI in pharma market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Oncologists Market Scope, Share Analysis And Growth 2025

Image
Crafted for informed planning, this report explores the forces reshaping the oncologists market and what they mean for business leaders. How Big Is The Oncologists Market In 2025? The oncologists market size has grown marginally in recent years. It will grow from $19.93 billion in 2024 to $20.21 billion in 2025 at a compound annual growth rate (CAGR) of 1.4%. The growth in the historic period can be attributed to increasing cancer incidence, therapeutic advancements, aging population, healthcare infrastructure development, awareness and early detection programs. The oncologists market size is expected to see steady growth in the next few years. It will grow to $23.99 billion in 2029 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to precision medicine and personalized therapies, emerging therapeutic modalities, global oncology collaboration, epidemiological shifts and new challenges, healthcare policy and economic factors. Major tre...
Read more

Global Digital Photography Market Analysis, Scope And Growth Opportunities 2025 To 2034

Image
Get 20% Off Market Intelligence Reports With Code ONLINE20 – Track Global Tariffs, Economic Shifts, and Sector Transformations What Will Be the Forecast Market Size of the Global Digital Photography Market by 2029? The digital photography market size has grown steadily in recent years. It will grow from $53.14 billion in 2024 to $55.74 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to smartphone integration, social media influence, internet connectivity, software development, and e-commerce in photography gear. The digital photography market size is expected to see strong growth in the next few years. It will grow to $70.95 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to artificial intelligence in imaging, virtual and augmented reality photography, subscription-based photography services, blockchain for copyright protection, and sustainability in...
Read more

Electronic Clinical Outcome Assessment Solutions Market Size, Scope And Growth 2025 To 2034

Image
Grab 20% Off With Code ONLINE20 On Global market Reports – Evaluate Global Trends, Market Risks, and Competitive Intelligence What Is the Predicted Market Size and CAGR of the Electronic Clinical Outcome Assessment Solutions Market by the End of the 2029? The electronic clinical outcome assessment solutions market size has grown rapidly in recent years. It will grow from $1.68 billion in 2024 to $1.94 billion in 2025 at a compound annual growth rate (CAGR) of 15.1%. The growth in the historic period can be attributed to regulatory support, patient-centric approach, data quality and accuracy, cost efficiency and time savings, increasing global clinical trials. The electronic clinical outcome assessment solutions market size is expected to see rapid growth in the next few years. It will grow to " $3.22 billion in 2029 at a compound annual growth rate (CAGR) of 13.6%. The growth in the forecast period can be attributed to integration with wearable devices, decentralized and hybrid tr...
Read more